Optical communications stocks surge overseas with major win: secure $460 million order from U.S. client | Selected after-hours announcements

An emerging company in the optical communications sector has secured RMB 460 million in orders from U.S. clients; a leader in precision medicine within the pharmaceutical industry is set to be acquired by a major state-owned enterprise; and a leading financial IT firm has crossed into a new venture, establishing a joint venture to tap into the 'computing power leasing' market... What notable announcements emerged after today's market close?

Golden10 DataJun 4 20:58

The IVD industry is undergoing consolidation, with equity stakes in several companies, including AmoyDx, facing changes.

Industry participants widely believe that the sector is undergoing accelerated consolidation.

lanjinger.comJun 3 16:48

AMOYDX(300685):2025 EARNINGS BEAT EXPECTATIONS WITH SIGNIFICANT RESULTS IN QUALITY AND EFFICIENCY ENHANCEMENT

Jun 3 10:16

Amoy Diagnostics Co., Ltd. (300685.SZ): Trading of the company's shares remains suspended, with the suspension expected to last no more than three trading days.

Gelonghui, June 2 — Amoy Diagnostics Co., Ltd. (SZSE: 300685) announced that, as of the date of this announcement, the relevant parties are actively advancing the aforementioned matter, and the company anticipates it will be unable to resume trading of its shares at the opening of the market on Wednesday, June 3, 2026. Given the significant uncertainty surrounding this matter, and in order to protect investors’ interests and avoid a material impact on the company’s share price, pursuant to the relevant provisions of the 'Listing Rules for the ChiNext Board of Shenzhen Stock Exchange' and the 'Guideline No. 6 for Self-Regulatory Supervision of Listed Companies of Shenzhen Stock Exchange – Suspension and Resumption of Trading,' the company has applied to the Shenzhen Stock Exchange for an extension of the trading suspension. The company's stock (stock abbreviation: Amoy Diagnostics, stock code:

Gelonghui FinanceJun 2 17:21

Amoy Top Bio-Tech Co., Ltd. (300685.SZ): Cumulatively repurchased 4,364,300 shares of the company's stock

Gelonghui, June 2 — Amoy Diagnostics Co., Ltd. (300685.SZ) announced that as of May 31, 2026, the company has repurchased 4,364,300 shares through its dedicated securities account via centralized bidding transactions, representing 1.12% of its current total share capital. The highest purchase price was RMB 22.53 per share, and the lowest was RMB 19.48 per share, with a total payment amounting to RMB 90,972,271.03 (excluding transaction fees).

Gelonghui FinanceJun 2 17:20

Express News | Nearly 30 A-share listed companies disclosed updates on their merger and acquisition activities this week; Adicon Biotechnology plans a change in control and will suspend trading of its shares starting tomorrow.

BreakingsMay 31 19:35